Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.38 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL211836 | 0.98 | TSHR (0.39) | TSHRGABRR1GABRR2BLMLMNA | |
| SCHEMBL6061868 | 0.96 | TSHR (0.38) | TSHRGABRR1GABRR2BLMLMNA | |
| Maleic Acid SCHEMBL4981536 | 0.96 | TSHR (0.38) | TSHRGABRR1GABRR2BLMLMNA | |
| Acrylic Acid SCHEMBL6444076 | 0.94 | LMNA (0.40) | TSHRGABRR1GABRR2BLMLMNA | |
| Vinyl Chloride SCHEMBL259499 | 0.92 | GABRR1 (0.35) | TSHRGABRR1GABRR2BLMLMNA | |
| Vinyl Chloride SCHEMBL6562575 | 0.92 | GABRR1 (0.35) | TSHRGABRR1GABRR2BLMLMNA | |
| Acetic Acid SCHEMBL6563939 | 0.92 | GABRR1 (0.35) | TSHRGABRR1GABRR2BLMLMNA | |
| Acrylic Acid SCHEMBL6562656 | 0.89 | LMNA (0.36) | TSHRGABRR1GABRR2BLMLMNA | |
| Methacrylic Acid SCHEMBL4684697 | 0.87 | GABRR1 (0.32) | TSHRGABRR1GABRR2BLMLMNA | |
| Acrylic Acid Methyl Ester SCHEMBL4672549 | 0.84 | HCAR2 (0.41) | TSHRGABRR1GABRR2BLMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111356501-A | Properties to achieve durable cosmetic Performance | 生活实验公司 | 2020-06-30 | — | — | CN | claimed |
| US-6685952-B1 | CONDITIONERS, SHAMPOOS, HAIR COLOR, SKIN LOTIONS; | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-02-03 | — | — | US | claimed |
| US-20010022967-A1 | Hair styling compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2001-09-20 | — | — | US | claimed |
| US-5730996-A | Intercalates and expoliates formed with organic pesticide compounds and compositions containing the same | AMCOL INTERNATIONAL CORPORATION (US) | 1998-03-24 | — | — | US | claimed |
| CN-111356501-A | Properties to achieve durable cosmetic Performance | 生活实验公司 | 2020-06-30 | — | — | CN | disclosed |
| US-20170298410-A1 | BREAST MILK ETHANOL SCREENING SYSTEM AND METHOD | UPSPRING, LTD. (US) | 2017-10-19 | — | — | US | disclosed |
| US-20130040289-A1 | BREAST MILK ETHANOL SCREENING SYSTEM AND METHOD | UPSPRING LTD. (US) | 2013-02-14 | — | — | US | disclosed |
| US-20100086616-A1 | BREAST MILK ETHANOL SCREENING SYSTEM AND METHOD | Upspring Ltd., Corporation (US) | 2010-04-08 | — | — | US | disclosed |
| US-7179451-B2 | Hair styling compositions | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| US-6685952-B1 | CONDITIONERS, SHAMPOOS, HAIR COLOR, SKIN LOTIONS; | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-02-03 | — | — | US | disclosed |
| EP-1198217-A1 | PERSONAL CARE COMPOSITIONS AND METHODS-HIGH INTERNAL PHASE WATER-IN-VOLATILE SILICONE OIL SYSTEMS | UNILEVER PLC (GB) | 2002-04-24 | — | — | EP | disclosed |
| US-20020004035-A1 | Hair styling gels | HELENE CURTIS, INC. | 2002-01-10 | — | — | US | disclosed |
| US-5730996-A | Intercalates and expoliates formed with organic pesticide compounds and compositions containing the same | AMCOL INTERNATIONAL CORPORATION (US) | 1998-03-24 | — | — | US | disclosed |
| US-5721306-A | EXFOLIATED PLATELETS FORMED BY CONTACTING LAYERED SILICATE MATERIAL WITH INTERCALANT POLYMER | AMCOL INTERNATIONAL CORPORATION (US) | 1998-02-24 | — | — | US | disclosed |
| EP-0808568-A1 | Intercalates and exfoliates formed with organic pesticide compounds and compositions containing the same | AMCOL INTERNATIONAL CORPORATION (US) | 1997-11-26 | — | — | EP | disclosed |
| EP-0747323-A1 | Intercalates; exfoliates; process for manufacturing intercalates and exfoliates and composite materials containing same | AMCOL INTERNATIONAL CORPORATION (US) | 1996-12-11 | — | — | EP | disclosed |
| EP-0747451-A2 | Intercalates and exfoliates formed with oligomers and polymers and composite materials containing same | AMCOL INTERNATIONAL CORPORATION (US) | 1996-12-11 | — | — | EP | disclosed |
| US-5578672-A | MIXING PHYLLOSILICATE WITH A POLYMER AND LIQUID CARRIER, EXTRUSION THROUGH DIE; COMPOSITES, AUTOMOBILE PARTS | AMCOL INTERNATIONAL CORPORATION (US) | 1996-11-26 | — | — | US | disclosed |
| US-5552469-A | SILICATE | AMCOL INTERNATIONAL CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
| EP-0524346-A1 | Composition and method for protecting hair against thermal degradation and to aid in hair styling | HELENE CURTIS, INC. (US) | 1993-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100086616-A1 | BREAST MILK ETHANOL SCREENING SYSTEM AND METHOD | CEL, LCT, GALK1 | TSHR 1489/4885GABRR1 2710/4885GABRR2 2651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.